These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 24782555

  • 1. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA.
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [Abstract] [Full Text] [Related]

  • 2. National survey of extended-interval aminoglycoside dosing in pediatric cystic fibrosis pulmonary exacerbations.
    Prescott WA.
    J Pediatr Pharmacol Ther; 2011 Oct; 16(4):262-9. PubMed ID: 22768010
    [Abstract] [Full Text] [Related]

  • 3. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA, Nagel JL.
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR, Bhatt J.
    Cochrane Database Syst Rev; 2010 Jan 20; (1):CD002009. PubMed ID: 20091528
    [Abstract] [Full Text] [Related]

  • 8. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.
    Young DC, Zobell JT, Stockmann C, Waters CD, Ampofo K, Sherwin CM, Spigarelli MG.
    Pediatr Pulmonol; 2013 Nov 20; 48(11):1047-61. PubMed ID: 24000183
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis.
    Ochs MA, Dillman NO, Caverly LJ, Chaffee VD.
    Pediatr Pulmonol; 2021 Dec 20; 56(12):3634-3643. PubMed ID: 33983680
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
    Coulthard KP, Peckham DG, Conway SP, Smith CA, Bell J, Turnidge J.
    J Cyst Fibros; 2007 Apr 20; 6(2):125-30. PubMed ID: 16829216
    [Abstract] [Full Text] [Related]

  • 14. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA.
    Intensive Care Med; 2002 Jul 20; 28(7):936-42. PubMed ID: 12122533
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey.
    Smyth AR, Campbell EL.
    J Cyst Fibros; 2014 Jul 20; 13(4):424-7. PubMed ID: 24332244
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.